Transfusion-Associated Microchimerism in Individuals Receiving a Blood Transfusion After a Traumatic Injury

• ClinicalTrials.gov Identifier: NCT00400192
• Recruitment Status: Completed
• First Posted: November 16, 2006
• Last Update Posted: April 15, 2013
• Sponsor: Blood Systems Research Institute
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Information provided by (Responsible Party): Blood Systems Research Institute

Study Description

Brief Summary:

Individuals who experience a traumatic injury often have a significant amount of blood loss and may require a blood transfusion. In some individuals who receive a blood transfusion, white blood cells from the donor's blood may remain in the body for years, a condition known as microchimerism. This study will examine the reasons why microchimerism occurs in some blood transfusion recipients and not others.

Condition or disease
Chimerism; Blood Transfusion; Wounds and Injuries

Detailed Description:

Approximately 20% of individuals who suffer a traumatic injury require a blood transfusion; of these, 10% to 15% experience a condition known as transfusion-associated microchimerism. This occurs when white blood cells, or leukocytes, from the donor's blood persist in the recipient long after the transfusion occurs. The genetically distinct donor cells can remain in the individual for decades, and may account for as many as 4% of the white blood cells in the recipient's body. This suggests that the donor cells are tolerated by the recipient's immune system. The purpose of this study is to examine the specific factors that predispose some blood transfusion recipients to develop microchimerism.

In this study, blood samples will be collected from injured individuals who arrive at the University of California at Davis Medical Center. Individuals who receive a blood transfusion, as well as a control group of individuals who do not receive a transfusion, will be approached to enroll in the study. Individuals who agree to participate will have their blood collected at Days 7, 14, and 28 and Months 3 and 6. Study researchers will analyze the blood for evidence of microchimerism. Participants with microchimerism will undergo additional blood collection at Months 12, 18, 24, 30, and 36. Information will be collected from all participants on health status, injury characteristics, hospital care, blood transfusion details, and blood donor characteristics.

Study Design

• Study Type: Observational
• Actual Enrollment: 451 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Prospective Study of the Kinetics and Mechanisms of Transfusion-associated Microchimerism in Injured Patients
• Study Start Date: November 2006
• Actual Primary Completion Date: August 2010
• Actual Study Completion Date: July 2012

Groups and Cohorts

Outcome Measures

Primary Outcome Measures :

1. Prevalence and magnitude of transfusion-associated microchimerism [ Time Frame: 1, 2 and 4 weeks, 3 and 6 months ]

Biospecimen Retention:   Samples With DNA

Whole blood, plasma, peripheral blood mononuclear cells

Eligibility Criteria

• Ages Eligible for Study: 12 Years and older (Child, Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No
• Sampling Method: Probability Sample

Study Population

Emergency Department

Criteria

Inclusion Criteria:

• Hospitalized for a traumatic injury
• Received at least one unit of transfused red blood cells

Exclusion Criteria:

• Currently incarcerated
• Inadequate decision-making capacity of the participant and no available surrogate decision-maker
• Prior bone marrow or solid organ transplantation

Contacts and Locations

Locations

United States, California

University of California, Davis, Medical Center

Sacramento, California, United States, 95817

Sponsors and Collaborators

Blood Systems Research Institute

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

• Principal Investigator: Michael P. Busch, MD, PhD; Blood Systems Research Institute

More Information

Publications:

Utter GH, Owings JT, Lee TH, Paglieroni TG, Reed WF, Gosselin RC, Holland PV, Busch MP. Blood transfusion is associated with donor leukocyte microchimerism in trauma patients. J Trauma. 2004 Oct;57(4):702-7; discussion 707-8.

Utter GH, Owings JT, Lee TH, Paglieroni TG, Reed WF, Gosselin RC, Holland PV, Busch MP. Microchimerism in transfused trauma patients is associated with diminished donor-specific lymphocyte response. J Trauma. 2005 May;58(5):925-31; discussion 931-2.

Lee TH, Paglieroni T, Utter GH, Chafets D, Gosselin RC, Reed W, Owings JT, Holland PV, Busch MP. High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion. 2005 Aug;45(8):1280-90.

• Responsible Party: Blood Systems Research Institute
• ClinicalTrials.gov Identifier: NCT00400192
• Other Study ID Numbers: 1362; R01HL083388 ( U.S. NIH Grant/Contract )
• First Posted: November 16, 2006
• Last Update Posted: April 15, 2013
• Last Verified: April 2013

Keywords provided by Blood Systems Research Institute:

Microchimerism; Injuries; Leukocytes; Immunologic Techniques

Additional relevant MeSH terms:

Wounds and Injuries